The human immunodeficiency virus (HIV) type 1 epidemic in many parts of sub-Saharan Africa is at least several decades old, considerably older than in other parts of the world, such as Asia. HIV burden for the African continent is estimated at 15-20 million, with heterosexual and perinatal transmission the major routes of infection [1] . Most of the 10 known HIV-1 subtypes have been reported in sub-Saharan Africa, although surveillance data on subtypes G, H, I, and J remain preliminary [2] [3] [4] [5] . Current information on the prevalence of HIV-1 subtypes is cross-sectional, frequently based on small numbers of samples that were readily available, and often derived from patients at different times during their HIV infection [2] . Thus, although studies in certain African countries have described multiple HIV-1 subtypes, it is not known whether subtypes entered these populations at different times or whether the distribution of subtypes reflects the dynamics of different subtype-specific transmission potentials. This prospective study was undertaken to determine the dynamics of various HIV-1 subtype infections in a high-risk population over a decade of observation.
The recognized differences in transmission and virulence of HIV-2, compared with HIV-1, indicate that HIV viruses can have different pathogenic potentials. Prospective studies that identified and followed seroincident infection were critical to the observation that HIV-2 was less transmissible and slower in disease progression than HIV-1 [6] [7] [8] . This lends support to the hypothesis that genetically distinct subtypes of HIV-1 might also differ in their biologic properties. Subtype differences in transmission and disease potential would drastically alter our predictions of the future of the HIV epidemic and its impact.
Estimates of the time to development of AIDS after HIV infection are long, variable, and based primarily on data from US and European studies with subtype B-infected persons. Although few data are available from the developing world, where non-B subtypes predominate, cross-sectional studies suggest that HIV non-B subtypes are common in AIDS patients [9, 10] . However, differences in pathogenicity between HIV subtypes might be best discerned from prospective studies, where the time to AIDS development can be estimated and compared. Given the known differences in the geographic distribution and associated epidemics of different HIV subtypes, we asked whether HIV-1 subtypes might differ in their rates of disease development. This study is the first to evaluate disease progression of different HIV-1 subtypes in a cohort of prospectively followed persons with known time of infection.
Methods
Since 1985, all women registered as prostitutes at the Institut d'Hygiène Sociale clinic in Dakar, Senegal, have been serologically screened for exposure to HIV-1 and HIV-2. The clinic provides clinical examinations and treatments of sexually transmitted diseases (STDs) during biannual visits, which are required for the legal registration of prostitutes. All women who gave informed consent were enrolled in the study, and a baseline questionnaire and health evaluation was administered by study physicians. The dynamic nature of this clinic resulted in an open cohort design in which subjects were continuously identified and enrolled over the study period. The study design, recruitment procedures, and various protocols have been described [6] [7] [8] 11] .
At the time of enrollment and at subsequent biannual visits, a complete physical examination was done that emphasized HIVrelated signs and symptoms. All biannual blood samples were tested for antibodies to each virus by immunoblot for HIV-1 and HIV-2 antibodies in the Dakar and Boston laboratories. T cell subsets were determined annually, and DNA was extracted from the peripheral blood mononuclear cells that remained after T cell subset analysis by proteinase K-phenol-chloroform extraction.
Seroincident HIV-1 cases were defined as women who were previously HIV-negative and subsequently seroconverted to HIV-1. The time of infection, or seroconversion date, was estimated as the midpoint between the last seronegative and first seropositive samples. HIV-1-positive person-years of observation was calculated from the seroconversion date until the AIDS disease outcome. AIDS was diagnosed by the CDC revised surveillance case definition, which includes !200 CD4 cells [12] . Cases were censored at their last clinic examination date or date of death (not caused by AIDS); the observation period ended on 1 January 1997. KaplanMeier AIDS-free survival analysis and Cox proportional hazards models for AIDS outcome were done as described (Stata, College Station, TX).
HIV-1 subtype was determined by polymerase chain reaction (PCR) amplification of ∼350 bp in the HIV-1 C2-V3 envelope region. A nested PCR was done using two sets of primers: WT1, 5 -GCTGGTTTTGCGATTCTAAAGTGTA (6884-6908, positions relative to HXB2) and WT2, 5 -CAATAGAAAAATTCC-CCTCCACAAT (7353-7377), for the first round; and published primers, KK30-KK40, for the second round [13] .
The PCR reactions were in a 100-mL volume reaction mixture containing 1 mg of DNA, 10 mL of 10ϫ PCR buffer II and 2.5 U of Taq polymerase (Perkin-Elmer PCR Reagents, Roche Molecular Systems, Branchburg, NJ), 0.2 mM of each dideoxy-nucleotide, 2 mM MgCl 2 , and 20 pmol of each primer. Each reaction was subjected to 30-35 cycles of denaturation (94ЊC, 45 s), annealing (45 s at 57ЊC and 55ЊC in the first and second rounds, respectively), and extension (72ЊC, 45 s), followed by a final extension (72ЊC, 3 min) in an automatic thermal cycler. Negative controls included deionized water and negative peripheral blood lymphocyte DNA in all experiments.
The PCR product was purified and directly sequenced using the second-round primers (KK30 and KK40). When necessary, the purified product was cloned in pCR2.1 vector (T/A cloning; Invitrogen, San Diego). Sequences were determined by dye terminator cycle sequencing using Taq polymerase and an automatic sequencer ABI 373A (both Perkin-Elmer, Applied Biosystem Division, Foster City, CA). In all cases, sequences were determined for both strands of DNA, and in many instances multiple clones were sequenced.
Multiple alignments were done with the Clustal package (W 1.6) with minor manual adjustment when necessary [14] . Phylogenetic analysis was performed by the neighbor-joining method, and reliability was estimated from 1000 bootstrap resamplings. Representative sequences of various HIV subtypes A-I were included in the analysis [2] . The nucleotide sequences were submitted to GenBank (accession numbers: AF085284-085327 and AF020819-020827).
In samples where envelope sequences could not be amplified, nested PCR in the long-terminal-repeat (LTR) region was done for subtype assignment. Oligonucleotide primers were designed on the basis of an analysis of conserved regions within the LTR across the clades represented in the Los Alamos (NM) National Laboratory HIV database (A-G, O). Upstream primers for the LTR were PH5 KPN. Downstream primers for the LTR were PH3 LTR and PH56 (PH5 KPN: 5 -CTCAGGTACCTTTAAGACC-3 ; PH3 LTR: 5 -CTGAGGGATCTCTAGTTACCAGAG-3 ; PH56: 5 -ATTGAGGCTTAAGCAGTGGG-3 ). Samples were subjected to 30-39 amplification cycles consisting of a denaturing step (94ЊC, 30 s), a primer annealing step (50ЊC, 30 s), and a primer extension step (72ЊC, 45 s).
Results
From February 1985 to December 1995, 1683 seronegative women were enrolled in the study and followed; 81 women subsequently seroconverted to HIV-1. DNA samples were available from 54 of the 81 HIV-1 seroconverters, and HIV-1 subtype was determined. HIV-1 subtype was assigned based on the C2-V3 sequence in 53 of 54 samples; LTR sequences were used for the remaining sample to determine subtype after the envelope sequences failed to provide subtype information. Subtypes were determined by phylogenetic tree analysis; based on 1000 bootstrap resamplings, high bootstrap values demonstrated the branching order of sequences with known HIV-1 subtypes A (93.4%), C (96.4%), D (92.1%), and G (99.0%) (figure 1).
Subtype A was found in 37 (68.5%) of 54 seroconverters, subtype C in 5 (9.3%), subtype D in 5 (9.3%), and subtype G in 6 (11.1%). One (1.8%) of the V3 envelope sequences had significant variation from other subtype A sequences. Examination by the Recombinant Identification Program [15] revealed a mosaic virus composed of subtypes A and G, which was further verified by sequencing of the complete gp120 portion of the envelope. Most of the gp120 aligned with subtype A, but ∼300 bp in the V2-C2 region aligned with subtype G. This woman was infected in 1994 and is currently healthy; she was not included in further analyses because of the mosaic virus. While HIV-1 subtype assignment utilizing the V3 envelope sequence has high specificity and sensitivity, it is inadequate to address the potential existence of recombinant or mosaic viruses [16, 17] . Thus, it is possible that other women in our study harbor viruses that are monotypic within the V3 region but mosaic or recombinant in other regions of the genome.
The distribution of seroconverters over the 10-year period is illustrated by HIV subtype designated at the estimated seroconversion date (figure 2). In this high-risk group of women, the first HIV-1 seroconversions occurred in late 1987. Throughout the study period, subtype A was the most common HIV-1 subtype. The first seroconversion to subtype C occurred late in 1987; the last C seroconversion was observed in late 1993. Similarly, subtype D was observed early in 1987 and then sporadically until early 1994. Subtype G infections first appeared in mid-1992 and in subsequent years represented 20% of the incident HIV-1 subtypes. We are cautious in our interpretation of the subtype dynamics in this cohort, since DNA samples were unavailable for 27 of the 81 HIV-1 seroconverters observed in the study. A logistic regression analysis, including age at registration, years of registered prostitution, nationality, and year of seroconversion, showed that women of Ghanaian nationality were less likely to be subtyped ( ). Ghanaian women represented a small P ϭ .02 fraction of all HIV-1 seroconverters in the study (18.8%), yet our results may be less generalizable to this subpopulation.
The prospective nature of the study allowed the clinical observation of women after seroconversion. Overall, we observed 11 cases of AIDS in the 54 women with subtype diagnosis. These women were followed for 199 person-years. The HIV-1 subtype-specific AIDS incidence rates per 100 person-years varied widely, from 3.45 (95% confidence interval [CI], 1.44-8.29) for subtype A to 15.95 for subtype C (95% CI, 5.14-49.45) and 14.45 for subtype D (95% CI, 4.66-44.81). No cases of AIDS were seen in the 6 women who were infected with subtype G relatively late in the study period.
Kaplan-Meier disease-free survival analysis was performed on seroincident women grouped by HIV subtype ( figure 3A) . The AIDS-free survival curves differed by HIV subtype (log rank test, ; Wilcoxon-Gehan, ). At 5 years of P ϭ .06 P ϭ .03 infection, 87.0% of women infected with subtype A were AIDSfree compared with 30.0% of subtype C-and 60.0% of subtype D-infected women. To adjust for other potentially confounding variables, we constructed a Cox proportional hazards model with AIDS as the outcome, controlling for nationality, age at registration, years of registered prostitution, and HIV subtype. The adjusted ratio for development of AIDS was 8.11 for subtype C (95% CI, 1.44-45.61; ) and 8.43 for subtype D P ϭ .02 (95% CI, 1.22-57.80; ) compared with subtype A. P ϭ .03 Since relatively few women were infected with subtypes C, D, and G, we analyzed AIDS-free survival probabilities in women with subtype A compared with those with non-subtype A HIV ( figure 3B ). The AIDS-free survival curves were distinct: Women infected with subtype A had a longer AIDS-free survival period than those infected with non-A subtypes; the 5-year AIDS-free survival probability was 87% in subtype Ainfected women versus 52% for non-subtype A-infected women (log rank test, ; Wilcoxon-Gehan, ). The Cox P ϭ .02 P ϭ .03 proportional hazards model estimated that women infected with a non-A subtype were 8.23 times more likely to develop AIDS than those infected with subtype A (95% CI, 1.70-39.8;
). P ϭ .009
In the prospective cohort study design, the evaluation of loss to follow-up is critical to the interpretation of the AIDS progression data. At the beginning of each calendar year, study physicians and social workers actively investigated enrolled women who had not attended the clinic for 112 months. In the 54 HIV-incident women with known HIV subtype, 4 (7.4%) Figure 3 . A, Kaplan-Meier AIDS-free survival in seroincident women by HIV-1 subtype ( , log rank; , Wilcoxon-Gehan). B, P ϭ .06 P ϭ .03 Kaplan-Meier AIDS-free survival analysis in seroincident women with HIV subtype A vs. all non-A subtypes ( , log rank; , Wilcoxon-P ϭ .02 P ϭ .03 Gehan).
were considered lost to follow-up after the 1997 active followup evaluation. We performed a sensitivity analysis in which these women were considered to have developed AIDS. Again, subtype A demonstrated a significantly longer AIDS-free survival and reduced rate ratio for AIDS development compared with non-A subtypes (95% CI, 0.07-0.74;
). Thus, we P ϭ .014 do not believe that differential follow-up in our study population was responsible for the subtype differences in progression to AIDS.
Misclassification bias must also be considered in the evaluation of our study results. Multiple methods have been used to assess viral subtype infection, including heteroduplex mobility shift assays, complete sequencing of the viral genome, and PCR sequencing of partial regions of the HIV genome [2, 3, 18] . Sequence analysis of the V3 envelope region is one of the more common methods for molecular epidemiology studies and has relatively high reliability in determining HIV-1 subtypes [2] . However, this does not rule out the possibility of mosaic genomes, which might only be detected through full genome sequencing [15] [16] [17] . Current data suggest that the number and complexity of HIV recombinants is ever expanding. The majority of sequences from subtype G viruses originate in West and Central Africa; our data suggest this may be a more recent HIV-1 subtype [2] . In addition, sequence analysis of subtype G viruses suggest that this subtype may frequently be a mosaic with subtype A [19] . In consideration of this, we grouped subtypes A and G together and compared disease progression rates to those of subtypes C and D. Subtypes A and G demonstrated a significantly longer AIDS-free survival and adjusted AIDS rate ratio (95% CI, 1.70-39.82;
). Therefore, despite P ϭ .009 the possibility of mosaic viruses, our classification of subtypes based on potential mosaicism still suggests distinct differences in disease progression.
Discussion
In recent years, there has been a growing appreciation of the role of HIV-1 subtypes in the complex epidemiology of the global HIV pandemic. Differences in sexual practices, rates of STDs, and other determinants of HIV infection and transmission also likely contribute to the different HIV epidemic curves observed worldwide. However, to date, studies of different subtypes have been limited to cross-sectional surveys. This is the first study that documents the introduction and spread of multiple HIV subtypes in a high-risk population studied over time.
Previous studies have estimated the rate of progression to AIDS in US and European cohorts. Although study designs and methods of analysis have varied, 65%-80% AIDS-free survival at 5 years has been reported in cohorts before the extensive use of antiviral therapy [20] [21] [22] [23] . The rate of disease progression in populations in the developing world has been poorly studied to date; our study cohort in Dakar, Senegal, provides the only data on AIDS progression in an incident cohort studied 15 years [8] . Studies concerning the natural history of chronic infections, such as HIV, are difficult to achieve. Nevertheless, our study has been successful in minimizing loss to follow-up through regular active follow-up and the efforts of a dedicated and compassionate clinical staff.
We believe our study is the first to evaluate disease progression in non-B subtype infections with known time of infection. In evaluating AIDS-free survival curves of women with incident A, C, D, and G infection, we found distinct differences in AIDSfree survival. The grouped comparison of non-A versus A subtypes demonstrated a significantly longer AIDS-free survival for women infected with subtype A. Due to the small sample size per subtype, with few AIDS cases despite a lengthy study period, our estimate of AIDS incidence should not be considered precise, and further study is clearly warranted. Cross-sectional studies indicate a significant proportion of AIDS cases with subtype A infection in West and East Africa (unpublished data) [24] . However, this is not inconsistent with our results should the proportion of subtype A in the high-risk population be quite elevated. Further study of HIV-1 subtype natural history and progression from different geographic regions is clearly needed to better evaluate the role of viral subtype differences and AIDS pathogenesis.
The recognition of the different HIV-1 subtypes has led many to question whether properties of HIV-1 infection and its consequences as a whole can be generalized among different subtypes. Our study provides the first evidence that HIV-1 subtypes may differ in their progression time to AIDS. The further investigation of these differences may be central to understanding the diversity of HIV-1 pathogenesis. The evolution of HIV-1 subtypes in human populations may have favored or even selected for diverse biologic properties. Such diversity could potentially affect the overall efficacy of HIV therapy or intervention strategies. Thus, the study of the natural biologic variation of the virus itself may provide important insights into the rational design of interventions to alter or interrupt disease progression.
